DNA Cleavage and Cytotoxic Activity of Copper(II) Complexes Based on Reduced Schiff Bases Derived From Salicylaldehyde and Amino Acids Cover

.blurhash-client-img { display: none !important; }

DNA Cleavage and Cytotoxic Activity of Copper(II) Complexes Based on Reduced Schiff Bases Derived From Salicylaldehyde and Amino Acids

European Pharmaceutical Journal

Volume 70 (2023): Issue s2 (December 2023)

By: Jana Korcová, Mária Húserková, Lucia Lintnerová and Jindra Valentová

Open Access

|Mar 2024

Authors

Jana Korcová

jana.korcova@fpharm.uniba.sk

Comenius University, Faculty of Pharmacy, Department of Chemical Theory of Drugs, Bratislava, Slovakia

Mária Húserková

Comenius University, Faculty of Pharmacy, Department of Chemical Theory of Drugs, Bratislava, Slovakia

Lucia Lintnerová

Comenius University, Faculty of Pharmacy, Department of Chemical Theory of Drugs, Bratislava, Slovakia

Jindra Valentová

Comenius University, Faculty of Pharmacy, Department of Chemical Theory of Drugs, Bratislava, Slovakia

DOI: https://doi.org/10.2478/afpuc-2024-0003 | Journal eISSN: 2453-6725

Journal RSS Feed

Language: English

Page range: 48 - 51

Submitted on: Oct 9, 2023

|

Accepted on: Feb 15, 2024

|

Published on: Mar 28, 2024

Published by: Comenius University in Bratislava, Faculty of Pharmacy

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

copper(II) complexes,

anticancer drugs,

DNA cleavage activity,

Related subjects:

Pharmacy, other

© 2024 Jana Korcová, Mária Húserková, Lucia Lintnerová, Jindra Valentová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 70 (2023): Issue s2 (December 2023)Next article